<DOC>
	<DOC>NCT01820520</DOC>
	<brief_summary>Study designed to evaluate the safety and efficacy of double staining with brilliant blue G 0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography, pattern reversal electroretinogram and multifocal electroretinogram.</brief_summary>
	<brief_title>Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery</brief_title>
	<detailed_description />
	<mesh_term>Retinal Perforations</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<criteria>Patient age 18 years of older Signing of informed consent Macular pathology requiring vitrectomy (epiretinal membrane, macular hole, vitreomacular traction syndrome) Diagnosis of glaucoma Known allergy to brilliant blue G</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>